Zhejiang Yatai Pharmaceutical Co., Ltd.

SZSE:002370.SZ

4.69 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 420.644373.44315.134514.885709.2911,132.393906.869762.342463.146375.602313.637316.045420.339435.224429.667415.432342.669275.802
Cost of Revenue 285.646239.835195.758251.295455.362626.3498.594458.376272.792231.618216.628247.771290.116307.757300.751301.79249.923207.333
Gross Profit 134.998133.606119.376263.591253.929506.093408.275303.966190.354143.98497.00968.274130.223127.467128.917113.64192.74568.469
Gross Profit Ratio 0.3210.3580.3790.5120.3580.4470.450.3990.4110.3830.3090.2160.310.2930.30.2740.2710.248
Reseach & Development Expenses 21.79526.13828.61837.34970.09957.20587.10253.99322.83415.91117.50318.68114.44714.92608.5173.0492.645
General & Administrative Expenses 17.27210.43714.13514.21223.14819.418-25.634-12.24212.0867.1976.165.9447.66712.84931.3897.4187.9487.546
Selling & Marketing Expenses 76.61372.429140.876205.433197.55156.806128.08266.41758.26445.53244.76551.23445.64930.24930.57827.43620.76517.117
SG&A 93.88582.867155.011219.645220.699176.224102.44854.17470.3552.72950.92557.17753.31643.09861.96734.85328.71324.663
Other Expenses 51.8933.76558.72365.21283.6890.028-0.0058.653.1512.778-0.015-2.6915.4260.301-0.0482.471-0.1970.112
Operating Expenses 161.037142.77242.352322.206374.487307.881245.158168.08127.50797.42292.43798.68687.6577.5364.09958.242.19135.328
Operating Income -63.453-16.171-122.975-58.616-120.558174.528163.45101.72562.96945.6185.815-28.63945.07747.98857.08246.13950.30127.342
Operating Income Ratio -0.151-0.043-0.39-0.114-0.170.1540.180.1330.1360.1210.019-0.0910.1070.110.1330.1110.1470.099
Total Other Income Expenses Net 51.89-119.147-101.18787.014-1,801.007-23.6560.329-25.5113.1391.8251.227-0.9197.87-1.649-7.783-6.831-0.489-5.687
Income Before Tax -11.564-135.318-224.16328.398-1,921.565174.556163.445110.37565.98648.3885.799-31.33150.44248.28857.03448.6150.06527.454
Income Before Tax Ratio -0.027-0.362-0.7110.055-2.7090.1540.180.1450.1420.1290.018-0.0990.120.1110.1330.1170.1460.1
Income Tax Expense 0.313-2.5974.1181.123-0.31222.02323.05411.5949.4977.820.319-5.6136.6476.2428.882710.9785.997
Net Income -11.877-132.72-228.2827.275-1,921.253150.946139.596.80155.49940.5685.48-25.71843.79542.04648.15241.6139.08721.457
Net Income Ratio -0.028-0.355-0.7240.053-2.7090.1330.1540.1270.120.1080.017-0.0810.1040.0970.1120.10.1140.078
EPS -0.02-0.25-0.430.051-3.580.280.260.220.140.10.015-0.0650.110.110.160.140.130.071
EPS Diluted -0.02-0.25-0.430.051-3.580.280.260.220.140.10.015-0.0650.110.110.160.140.130.071
EBITDA 80.61825.443-88.062-19.692-1,188.227245.675207.9187.565100.43378.18133.603-5.21472.90470.47579.90768.80257.05531.759
EBITDA Ratio 0.1920.068-0.279-0.038-1.6750.2170.2290.2460.2170.2080.107-0.0160.1730.1620.1860.1660.1670.115